Skip to content

Effects of Fluid Balance Control in Critically Ill Patients

Effects of Fluid Balance Control in Critically Ill Patients: A Multicenter Randomized Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02765009
Acronym
POINCARE
Enrollment
1411
Registered
2016-05-06
Start date
2016-06-01
Completion date
2020-05-25
Last updated
2020-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fluid Shifts, Critical Care

Keywords

Fluid overload, Multiple organ failure, Diuretics, Fluid restriction, Body weight

Brief summary

Most ICU patients develop a positive fluid balance, mainly during the two first weeks of their stay. The causes are multifactorial: a reduced urine output subsequent to shock state, positive pressure mechanical ventilation, acute renal failure, post-operative period of major surgical procedures, and simultaneous fluid loading to maintain volemia and acceptable arterial pressure. Additionally, the efficacy of fluid loading is frequently suboptimal, in relation to severe hypoalbuminemia and inflammatory capillary leakage. This results usually in a cumulated positive fluid balance of more than 10 litres at the end of the first week of stay. A high number of studies have showed that such a positive fluid balance was an independent factor of worse prognosis in selected populations of ICU patients: acute renal failure, acute respiratory distress syndrome (ARDS), sepsis, post-operative of high risk surgery. However, little is known about the putative causal role of positive fluid balance by itself on outcome. However, in two randomized controlled studies in patients with ARDS, a strategy of fluid balance control has been demonstrated to reduce time under mechanical ventilation and ICU length of stay with no noticeable adverse effects. Although avoiding fluid overload is now recommended in ARDS management, there is no evidence that this approach would be beneficial in a more general population of ICU patients (i.e. with sepsis, acute renal failure, mechanical ventilation). In addition, fluid restriction -mainly if applied early could be deleterious in reducing both tissue oxygen delivery and perfusion pressure. There is a place for a prospective study comparing a conventional attitude based on liberal fluid management throughout the ICU stay with a restrictive approach aiming at controlling fluid balance, at least as soon as the patient circulatory status is stabilized. The latter approach would use a simple algorithm using fluid restriction and diuretics based on daily weighing, a common procedure in the ICU, probably more reliable than cumulative measurement of fluid movements in patients whose limits have been underlined.

Interventions

Used to reduce fluid overload as evidenced by weight gain

DRUGalbumin

Used to reduce fluid overload in addition with diuretics in hypoalbuminemic patients

Used to reduce fluid overload

DEVICErenal replacement

Used to reduce fluid overload in patients with renal replacement

Sponsors

Ministry of Health, France
CollaboratorOTHER_GOV
Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients under mechanical ventilation, admitted for \> 48h and \<72h and no discharge planned for the next 24h

Exclusion criteria

* Age \< 18 years * Failure to weigh the patient * Multiple trauma * Transfer from another ICU with a previous stay \> 24h * High probability of withdrawing treatment for ethical purposes within 7 days * Pregnancy * Patient refusal

Design outcomes

Primary

MeasureTime frameDescription
All-cause mortality at 60 days after inclusion60 daysVital status collected 60 days after admission; if the patient was dead at the time of assessment, date of death was collected

Secondary

MeasureTime frameDescription
Fluid balance control at day 1414 daysMean differences of patient body weight between Day 14 and admission (Day 0)
All-cause mortality at 28-day after inclusion28 daysVital status collected 28 days after admission
All-cause in-hospital mortalityUp to 24 weeksDeath during the hospital stay where the patient was included in the study
All-cause mortality at 365 days after inclusion365 daysVital status collected one year after admission
Survival time period at Day 6060 daysTime-related mortality, calculated from admission to the date of death
Fluid balance control at day 77 daysMean differences of patient body weight between Day 7 and admission (Day 0)
Global end-organ damage assessment28 daysTime-related changes of Sequential Organ Failure Assessment (SOFA score): SOFA is a score of organ failure with 6 subscales on organ dysfunction: respiratory, neurological, cardiovascular,hepatic,renal and coagulation. Each ranges from 0 to 4 and the total SOFA score is the sum of each subscale ; increasing severity from 0 (normal) to 24(moribund). Values of SOFA score are tightly correlated with mortality.
Dependence on vasopressor drugs28 daysCumulated number of vasopressor-free days alive from day 0 to day 28
Dependence on mechanical ventilation28 daysCumulated number of ventilator-free days alive from day 0 to day 28
Dependence on renal replacement therapy60 daysCumulated number of renal replacement-free days alive from day 0 to day 60
Cumulated number of pre-defined adverse events14 daysPre-defined adverse events include Systolic arterial pressure\< 90 mm Hg, kalemia \< 2,8 ,mmol/L, natremia \>155 mmol/L, injury level of renal dysfunction (RIFLE scale), acute ischemic events (myocardial infarction, mesenteric ischemia)
Survival time period at Day 365365 daysTime-related mortality, calculated from admission to the date of death

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026